Escobar Ruling Helps Genentech Beat Avastin FCA Suit

By Jeff Overley (May 1, 2017, 7:41 PM EDT) -- The Third Circuit on Monday nixed a False Claims Act suit accusing Genentech Inc. of defrauding Medicare by concealing side effects of its blockbuster cancer drug Avastin, saying a whistleblower didn't show that failing to report safety information was relevant to government reimbursement for the medication....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!